Creating powerful collaborations that deliver impact in cell and gene therapies

CGT Catapult is an independent innovation and technology organisation committed to the advancement of cell and gene therapies, with a vision for a thriving industry delivering life-changing advanced therapies to the world.

We are a team of experts covering all aspects of advanced therapies. Applying our unique capabilities and assets, we collaborate with academia, industry, and healthcare providers to develop new technology and drive innovation.

CGT Catapult

We help companies, researchers and innovators accelerate their cell and gene therapy to market throughout development, manufacturing and clinical adoption.

The catapult network

CGT Catapult is part of a network of world-leading technology and innovation centres, established by Innovate UK. The Catapult Network foster collaborations between industry, government, research organisations, academia, and many others to transform great ideas into valuable products and services.

Learn more about the catapult model

Gender Pay Gap Reports

The Cell and Gene Therapy Catapult is legally obliged to report on its gender pay gap. Please see the link below for our latest data, which was collected on 5th April 2023 and has been analysed by a independent expert:

Gender pay report 2023/24

Previous reports:

Gender pay report 2022/23

Gender pay report 2021/22

Creating opportunities across the UK

Our outputs leverage research, transform barriers into industrial advantage and help to attract new investment for our collaborators.

We support people to acquire new skills, organisations to establish new capabilities and policymakers to develop new perspectives.

Learn how we are delivering impact for the UK